Treating ALS Visalia CA

Researchers in Visalia now believe that ALS, or amyotrophic lateral sclerosis, starts well before its debilitating symptoms appear, a finding that they say could eventually lead to an effective treatment.

Lawrence F Pearson MD
(559) 627-6165
419 W Murray Ave
Visalia, CA
Specialties
Obstetrics & Gynecology

Data Provided by:
Dr. Randy Bernabe
(559) 589-6294
1560 W. Lacey Blvd.
Hanford, CA
Business
Advanced Orthopedics
Specialties
Orthopedics
Insurance
Insurance Plans Accepted: We accept most PPO's, HMO's, private insurance, Medicare, and Worker Comp insurance.
Medicare Accepted: Yes
Workmens Comp Accepted: Yes
Accepts Uninsured Patients: No
Emergency Care: No

Doctor Information
Primary Hospital: Hanford Community Medical Center
Residency Training: Ohio University at Cuyahoga Falls General Hospital,
Medical School: Des Moines University, College of Osteopathic Medicine and Health Sciences,, 1994
Additional Information
Languages Spoken: English,Spanish,Tagalog

Data Provided by:
Chawki Gerges
(559) 636-1168
128 N Akers St
Visalia, CA
Specialty
Internal Medicine

Data Provided by:
Raman Verma
(559) 713-1111
1821 W Meadow Ave Ste A
Visalia, CA
Specialty
Internal Medicine

Data Provided by:
Dennis Elwood Johnson
(559) 625-8898
1610 S Court St
Visalia, CA
Specialty
Cardiology, Internal Medicine

Data Provided by:
Mendonca Chiropractic Group
(559) 759-6996
1699 E Prosperity Ave
Tulare, CA

Data Provided by:
William C Holvik
(559) 732-4726
202 W Willow Ave
Visalia, CA
Specialty
Family Practice

Data Provided by:
James William Foxe
(559) 738-8584
1860 S Central St
Visalia, CA
Specialty
Family Practice

Data Provided by:
Kusai S Aziz
(559) 735-0500
101 E Noble Ave
Visalia, CA
Specialty
Cardiology, Internal Medicine, Cardiovascular Disease

Data Provided by:
Peter Stephen Caballes
(559) 741-4500
400 E Oak Ave
Visalia, CA
Specialty
Family Practice

Data Provided by:
Data Provided by:

Treating ALS

Provided By:

MONDAY, JUNE 15 (HealthDay News) -- Researchers now believe that ALS, or amyotrophic lateral sclerosis, starts well before its debilitating symptoms appear, a finding that they say could eventually lead to an effective treatment.

Protein clumps in cells that show up only after damage has occurred, rather than at the onset of the disease, appear responsible for the paralyzing course of ALS (amyotrophic lateral sclerosis), according to University of Florida researchers.

The research team found that the formation of these clumps of defective proteins and cell matter, called "protein aggregates," actually signals that ALS is progressing at a rapid pace.

In ALS, nerve cells extending from the brain to the spinal cord and then to the muscles die off. Its cause is unknown, though an inherited defective gene is suspected in up to 20 percent of cases. Scientists thought it originated with malformed -- or "misfolded" -- proteins that malfunction and lead to the protein aggregates in the brain.

The ALS Association says that about 30,000 Americans have the disease, which is often referred to as Lou Gehrig's disease, after the renowned ballplayer who died of ALS.

The Florida researchers examined the gene that produces superoxide dismutase 1, or SOD1, an enzyme that fights off free radicals -- molecules that damage the body's cells. People with the inherited version of ALS have been found to have one of the 146 known mutations in the SOD1 gene.

In the online edition of Human Molecular Genetics, the researchers wrote that the SOD1 mutations most likely to cause the protein clumps were also linked to the disease's faster progression.

Another study, recently published online in the Proceedings of the National Academy of Sciences, found that mice genetically altered to have ALS experience cell damage well before protein aggregates start to appear, a time that coincides with telltale symptoms of the disease.

"As the disease enters the symptomatic stage in mice, the buildup of protein is rapid and dramatic," David Borchelt, director of the SantaFe HealthCare Alzheimer's Disease Research Center at the university's McKnight Brain Institute, where the studies took place, said in a university news release. "However, the formation of these aggregates is not the whole story. It is well-established that significant damage to the nervous system occurs well before the symptoms appear. The uncontrolled misfolding of SOD1 seems to be confined to the late stage of disease, which is when symptoms first appear, giving hope that treatments targeting this process could be beneficial."

The finding suggests that there may be significant time to treat ALS before the clumping and symptoms appear, signaling the quickening pace of progression. But this would require development of an accurate way to diagnose ALS before symptoms emerge.

"Blocking aggregation of these proteins could be a therapeutic target for individuals with this genetic mutation," Borchelt said. "Right now, there is little that can be done to help these patients."

More information

The ALS Association has more about ALS.

SOURCE: University of Florida, news release, June 8, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com